Cardiac Drugs in Pregnancy

Karen Sliwa, John Anthony

$115.95 $92.71

Paperback

Not in-store but you can order this
How long will it take?

Availability Information

We source books from suppliers in Australia and overseas. For books we don't currently have in stock, the time it takes to get them from our suppliers can vary widely - from a few days to a few months - so we check each book with each supplier to determine the expected time it will take to be supplied to us.

We then advise you accordingly. If the time taken to get any book is too long for you, you can let us know and we will cancel or adjust your order, and refund as required.

To find out the anticipated arrival time for specific items prior to ordering, please contact us by phone or email:

Phone +61 2 9264 3111, or 1800 4 BOOKS (1800 4 26657) if outside Sydney:
option 1 Abbey's Bookshop (Crime, History, Science, Kids & more) • info@abbeys.com.au
option 2 Language Book Centre (ESL & Foreign Languages) • language@abbeys.com.au
option 3 Galaxy Bookshop (Sci-fi, Fantasy, Romance, Graphic Novels) • sf@galaxybooks.com.au

QTY:

English

Springer London Ltd
11 December 2013

Cardiovascular medicine; Materno-fetal medicine; Pharmacology

Series: Current Cardiovascular Therapy

The spectrum of cardiovascular disease affecting women in pregnancy and postpartum is changing and differs between countries. In the western world, the risk of cardiovascular disease in pregnancy has increased due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading also to early diabetes and hypertension. In addition the treatment of congenital heart disease has improved leading to an increased number of women with residual heart disease reaching childbearing age. In the western world maternal heart disease is now the major cause of maternal death during pregnancy. In the developing world rheumatic heart disease and the cardiomyopathies dominate. Those women often need anticoagulation as they might have had a valve replacement or formed a thrombus in the left heart. Drugs during pregnancy and the breastfeeding period is a complex subject and there is a profound shortage of evidence based recommendations. As drug treatment in pregnancy concern the mother and the fetus optimum treatment of both must be targeted.

This book aims at discussing the most important indications of drug usage in pregnancy and postpartum with the aim of weighing the potential risk of a drug and the possible benefit against each other.

Edited by: Karen Sliwa, John Anthony
Imprint: Springer London Ltd
Country of Publication: United Kingdom
Edition: 2014 ed.
Dimensions: Height: 203mm, Width: 127mm, Spine: 8mm
Weight: 1.808kg
ISBN: 9781447154716
ISBN 10: 1447154711
Series: Current Cardiovascular Therapy
Pages: 131
Publication Date: 11 December 2013
Audience: Professional and scholarly , Undergraduate
Format: Paperback
Publisher's Status: Active

Professor Karen Sliwa-Hähnle, MD, PhD, FESC, FACC, DTM&H, is Director of the Hatter Institute for Cardiovascular Research in Africa (HICRA) and Professor at the Department of Medicine and Institute of Infectious Diseases and Molecular Medicine University of Cape Town, South Africa. Professor John Anthony, MB, ChB, FCOG, MPhil, is Head of the Department of Obstetrics & Gynaecology at Groote Schuur Hospital, Cape Town, South Africa.

Reviews for Cardiac Drugs in Pregnancy

This handy book, written by distinguished authors in the field, consists of six chapters illustrating pharmacological treatment of different heart diseases during pregnancy. ... The book is an easy and enjoyable reading. ... the content is easily comprehensible and the book has a universal appeal, as it includes treatment in countries with different facilities. In addition, the pocket format is pleasing and practical for the everyday clinician. (Maria Schaufelberger, European Heart Journal, Vol. 36 (18), 2015)